Announcements Trials
Browse Landscape

Status

Recruiting 2Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Observational 3

Sponsor

Cancer Type

Gynecologic 1Genitourinary 1Breast 1

Conditions

Neoplasms 86Breast Neoplasms 70Prostatic Neoplasms 34Head and Neck Neoplasms 26Lung Neoplasms 24Colorectal Neoplasms 24Ovarian Neoplasms 22Uterine Cervical Neoplasms 21Endometrial Neoplasms 16Brain Neoplasms 15Rectal Neoplasms 12Pancreatic Neoplasms 11Colonic Neoplasms 11Urinary Bladder Neoplasms 9Melanoma 9Lymphoma 9Leukemia 9Depression 9Stomach Neoplasms 8Pain 8Motor Activity 8Colorectal Neoplasms, Hereditary Nonpolyposis 8Sarcoma 7Oropharyngeal Neoplasms 7Multiple Myeloma 7Hematologic Neoplasms 7COVID-19 7Vulvar Neoplasms 6Health Behavior 6Glioma 6

Interventions

Surveys and Questionnaires 3pazopanib 2Sunitinib 2Sorafenib 2Bevacizumab 2Patient Reported Outcome Measures 1Medical Records 1Data Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Observational × Financial Stress × Surveys and Questionnaires × Clear all
NCT06955910 2026-05-12

Assessing Financial Toxicity Using the PROFFIT Questionnaire in Patients Treated With Mini-invasive Approach for Urological Malignancies.

Istituto Oncologico Veneto IRCCS

Active not recruiting
120 enrolled
Genitourinary

Financial Stress, Urinary Bladder Neoplasms, Kidney Neoplasms, Prostatic Neoplasms

NCT07354165 2026-01-21

VOICE - GIM36

National Cancer Institute, Naples

Recruiting
864 enrolled
Breast

Financial Stress, Breast Neoplasms

NCT06032975 2023-11-13

MITO45-ProFFiT

National Cancer Institute, Naples

Recruiting
240 enrolled
Gynecologic

Financial Stress, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡